Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by mavericks2020on Jul 13, 2021 11:52am
219 Views
Post# 33535921

volume

volume
V:CLAS - CLARITAS PHARMACEUTICALS INC - https://claritaspharma.com 11:50:52 EDT
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
CLAS - V   10349.0 0.02 · 0.025 213.0 0.025 +0.005 25.0 178.1 5 7 0.02  0.025  0.02 0.11  0.02 11:26:26 Jun 23 15 min RT 2¢
TSX-V - V 10349.0 0.02 · 0.025 213.0 0.025 +0.005 25.0 168.1 4 6 0.02  0.025  0.02 0.11  0.02 11:26:26   15 min
CX2 - H   0.025 +0.005 25.0 10.0 0 1 0.025  0.025  0.025   09:31:28   15 min

 

Recent Trades - All 7 today
Time ET Ex Price Change Volume Buyer Seller Markers
11:26:26 V 0.025 0.005 6,000 7 TD Sec 9 BMO Nesbitt K
11:26:26 V 0.025 0.005 94,000 7 TD Sec 7 TD Sec K
11:06:14 V 0.025 0.005 15,000 7 TD Sec 7 TD Sec K
09:31:28 H 0.025 0.005 10,000 80 National Bank 1 Anonymous K
09:31:16 V 0.025 0.005 50,000 79 CIBC 9 BMO Nesbitt K
09:30:00 V 0.02   138 68 Leede 2 RBC  
09:30:00 V 0.02   3,000 2 RBC 2 RBC KL
               
               
               
 

 

 

 

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

 
 

 

 

 

<< Previous
Bullboard Posts
Next >>